Preparation, writing and redaction of clinical study reports

BlueReg can support in preparing and writing clinical study reports

Providing the redaction proposal document package for submission to the European Medicines Agency (EMA); anonymising individual patient data (IPD) and redacting commercially confidential information (CCI) to comply with EMA policy 0070 on the publication of clinical data for medicinal products for human use.

 

 

Associated services

Scientific and CTD Dossier Writing

BlueReg provide flexible solutions for scientific writing covering all kinds of engagements or operational platforms to meet your company’s needs from product development, registration through to launch and product maintenance activities.  Our team are experienced in writing clinical modules for submission in the EU and the US, PIPs, ODDs, INDs, IMPDs and IBs, as well as briefing packages for scientific advice.  The team also manage Chemistry Manufacturing and Controls (CMC) writing for chemical and biological products.

Associated services

CMC Regulatory support

Our CMC Regulatory support services include everything from regulatory strategy and preparation of meetings with health authorities, assessment and preparation of regulatory documents, responses to agency questions, maintenance of products on market, regulatory compliance strategy worldwide and geographical roll out.

Associated services

Safety reports

Bluereg has extensive experience in writing safety documents and can support you with assessing a product’s risk benefit profile for your product. 

Associated News

eCTD Format Mandatory for EU National Procedures

After CP, DCP/MRP Procedures, and according to the eSubmissions Roadmap Timelines, eCTD format is now...

Download now

Consulting Regulatory Affairs Services for Pharmaceutical companies

  The regulatory affairs process is a critical component of the safe development, registration and...

Download now